Institute for Wealth Management’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
TCM
BC
B
Institute for Wealth Management's ANAB Position: Q1 2023 in Review
Institute for Wealth Management sold out of AnaptysBio (ANAB) in Q1 2023, closing a stake of 8,055 shares — an estimated $250K sold.
Institute for Wealth Management first reported a position in ANAB in Q1 2021 and held it in 8 quarters. The position peaked at $322K in Q3 2021. 113 funds tracked by Wall St. Rank hold ANAB as of Q1 2023.
- Institute for Wealth Management reported no remaining AnaptysBio position as of Q1 2023 after selling out during the quarter.
- Institute for Wealth Management sold 8,055 AnaptysBio shares in Q1 2023, an estimated $250K.
- Institute for Wealth Management first reported a position in AnaptysBio in Q1 2021 and held it in 8 quarters.
- Institute for Wealth Management's AnaptysBio position peaked at $322K in Q3 2021.
- 113 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2023.
Based on Institute for Wealth Management's 13F filing for Q1 2023, filed 20 Apr 2023.